These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38986555)

  • 1. Yorkshire Lung Screening Trial (YLST) pathway navigation study: a protocol for a nested randomised controlled trial to evaluate the effect of a pathway navigation intervention on lung cancer screening uptake.
    McInnerney D; Simmonds I; Hancock N; Rogerson S; Lindop J; Gabe R; Vulkan D; Marshall C; Crosbie PAJ; Callister MEJ; Quaife SL
    BMJ Open; 2024 Jul; 14(7):e084577. PubMed ID: 38986555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk.
    Crosbie PA; Gabe R; Simmonds I; Kennedy M; Rogerson S; Ahmed N; Baldwin DR; Booton R; Cochrane A; Darby M; Franks K; Hinde S; Janes SM; Macleod U; Messenger M; Moller H; Murray RL; Neal RD; Quaife SL; Sculpher M; Tharmanathan P; Torgerson D; Callister ME
    BMJ Open; 2020 Sep; 10(9):e037075. PubMed ID: 32912947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Yorkshire Kidney Screening Trial (YKST): protocol for a feasibility study of adding non-contrast abdominal CT scanning to screen for kidney cancer and other abdominal pathology within a trial of community-based CT screening for lung cancer.
    Usher-Smith JA; Godoy A; Burge SW; Burbidge S; Cartledge J; Crosbie PAJ; Eckert C; Farquhar F; Hammond D; Hancock N; Iball GR; Kimuli M; Masson G; Neal RD; Rogerson S; Rossi SH; Sala E; Smith A; Sharp SJ; Simmonds I; Wallace T; Ward M; Callister MEJ; Stewart GD
    BMJ Open; 2022 Sep; 12(9):e063018. PubMed ID: 36127097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
    Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
    Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yorkshire Enhanced Stop Smoking (YESS) study: a protocol for a randomised controlled trial to evaluate the effect of adding a personalised smoking cessation intervention to a lung cancer screening programme.
    Murray RL; Brain K; Britton J; Quinn-Scoggins HD; Lewis S; McCutchan GM; Quaife SL; Wu Q; Ashurst A; Baldwin D; Crosbie PAJ; Neal RD; Parrott S; Rogerson S; Thorley R; Callister ME
    BMJ Open; 2020 Sep; 10(9):e037086. PubMed ID: 32912948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the effectiveness and cost-effectiveness of text-message reminders and telephone patient navigation to improve the uptake of faecal immunochemical test screening among non-responders in London: a randomised controlled trial protocol.
    Duffy T; Gil N; Siddique B; Duffy S; Prentice A; Marshall S; Djedovic NK; Lewis M; Ruwende J; von Wagner C; Kerrison R
    BMJ Open; 2024 Jun; 14(6):e079482. PubMed ID: 38909999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients.
    Quaife SL; Ruparel M; Beeken RJ; McEwen A; Isitt J; Nolan G; Sennett K; Baldwin DR; Duffy SW; Janes SM; Wardle J
    BMC Cancer; 2016 Apr; 16():281. PubMed ID: 27098676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using primary care-based paper and telephone interventions to increase uptake of bowel scope screening in Yorkshire: a protocol of a randomised controlled trial.
    McGregor LM; Kerrison RS; Green T; Macleod U; Hughes M; Gibbins M; Morris S; Rees C; von Wagner C
    BMJ Open; 2018 Jul; 8(7):e024616. PubMed ID: 30056395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using specialist screening practitioners (SSPs) to increase uptake of bowel scope (flexible sigmoidoscopy) screening: results of a feasibility single-stage phase II randomised trial.
    McGregor LM; Skrobanski H; Ritchie M; Berkman L; Miller H; Freeman M; Patel N; Morris S; Rees C; von Wagner C
    BMJ Open; 2019 Feb; 9(2):e023801. PubMed ID: 30772850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of adding a non-contrast abdominal CT scan to screen for kidney cancer and other abdominal pathology within a community-based CT screening programme for lung cancer: A qualitative study.
    Usher-Smith JA; Masson G; Godoy A; Burge SW; Kitt J; Farquhar F; Cartledge J; Kimuli M; Burbidge S; Crosbie PAJ; Eckert C; Hancock N; Iball GR; Rogerson S; Rossi SH; Smith A; Simmonds I; Wallace T; Ward M; Callister MEJ; Stewart GD
    PLoS One; 2024; 19(7):e0300313. PubMed ID: 38950010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient navigation to promote lung cancer screening in a community health center for people experiencing homelessness: Protocol for a pragmatic randomized controlled trial.
    Baggett TP; Barbosa Teixeira J; Rodriguez EC; Anandakugan N; Sporn N; Chang Y; Percac-Lima S; Park ER; Rigotti NA
    Contemp Clin Trials; 2022 Feb; 113():106666. PubMed ID: 34971796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invitation methods for Indigenous New Zealand Māori in lung cancer screening: Protocol for a pragmatic cluster randomized controlled trial.
    Parker K; Colhoun S; Bartholomew K; Sandiford P; Lewis C; Milne D; McKeage M; McKree Jansen R; Fong KM; Marshall H; Tammemägi M; Rankin NM; Hotu S; Young R; Hopkins R; Walker N; Brown R; Crengle S
    PLoS One; 2023; 18(8):e0281420. PubMed ID: 37527237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
    Kitchener HC; Gittins M; Rivero-Arias O; Tsiachristas A; Cruickshank M; Gray A; Brabin L; Torgerson D; Crosbie EJ; Sargent A; Roberts C
    Health Technol Assess; 2016 Sep; 20(68):1-138. PubMed ID: 27632816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Specialist Screening Practitioners (SSPs) to increase uptake of the Bowel Scope (Flexible Sigmoidoscopy) Screening Programme: a study protocol for a feasibility single-stage phase II trial.
    McGregor LM; Skrobanski H; Miller H; Ritchie M; Berkman L; Morris S; Rees C; von Wagner C
    Pilot Feasibility Stud; 2016; 2():54. PubMed ID: 27965871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population.
    von Wagner C; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Macleod U; Duffy S
    BMJ Open; 2018 May; 8(5):e022263. PubMed ID: 29730633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.